Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Lonza buys Shire’s U.S. clinical manufacturing site

Written by: | no-reply@reuters.com | Dated: Tuesday, October 3rd, 2017

 

Lonza buys U.S. clinical manufacturing site from Shire

 

ZURICH (Reuters) – Lonza Group is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire PLC, the Swiss pharmaceutical ingredients group said on Tuesday without giving the purchase price.

The site in California has a successful regulatory track record and includes single-use bioreactors and associated downstream capabilities, Lonza said. The site employs more than 100 staff who will have the chance to keep working for Lonza, it added.

 

Reporting by Michael Shields

 

Reuters source:

http://www.reuters.com/article/us-lonza-shire/lonza-buys-u-s-clinical-manufacturing-site-from-shire-idUSKCN1C81PY

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2017 Focus: Manufacturer of the Year, Top 50 Pharma, HBA and more!

Subscribe

Ad Right Bottom

Main Navigation